ABHI US Accelerator Enters Next Phase with Enhanced Nationwide Programme
One of ABHI's core roles is to provide the right environment for UK businesses to connect with new customers around the world. In recent years, we have focussed much of our activity on supporting UK companies enter and grow in the US, through the dedicated ABHI US Accelerator programme. I am delighted, therefore, to announce its expansion.
Building on the significant network we have developed in Texas, the ABHI US Accelerator is now a national offering, enabling deep connections to the network of institutions and hospital groups we have developed across the US. Currently, 16 companies are taking advantage of this offer - its platform having led to over 25 research projects and new business generated for UK industry.
Our enhanced offer connects UK businesses to a host of in-market specialists, designed to guide companies on critical issues, such as regulation, reimbursement and technology appraisal. The programme also facilitates introductions to hospital executives, clinical champions and supply chain leaders, allowing companies to liaise directly with decision-makers to build evidence and support adoption.
Participating companies have full use of ABHI’s dedicated workspace and office at the Dell Medical School in Austin, with access to their facilities and the support of senior faculty. ABHI US Accelerator members will also now benefit from a nationwide mission programme, delivering more personal and lasting ties with the networks we have cultivated over the years.
There are 30 places available for the 2020 cohort, with applications now open. More information is available here. For an informal discussion on the opportunity, please do contact me directly at paul.benton@abhi.org.uk
With best regards,
